uBiome, the leading microbial genomics company, uses next generation high-throughput DNA sequencing technology to generate detailed analyses of the human microbiome, the ecosystem of trillions of bacteria that live in and on the human body. While the majority of an individual’s bacteria is found in the gut, there are dozens of other bacteria-harboring sites on the body, most with their own distinct microbial profiles.
Individuals can have their own microbiomes tested by uBiome using a straightforward self-swabbed sample, returned by mail. Analysis is currently provided for five sites – gut, oral, nose, genitals, and skin.
uBiome was launched in 2012 by scientists and technologists educated at Stanford and UCSF after a crowdfunding campaign raised over $350,000 from citizen scientists, over triple its initial goal. The company is funded by Andreessen Horowitz, Y Combinator, and other leading investors.
uBiome’s mission is to use big data to understand the human microbiome by giving users the power to learn about their bodies, perform experiments, and see how current research studies apply to them.
Trackback from your site.